THYROCARE Quarterly Results, Profit & Loss, Balance Sheet (THYROCARE)

THYROCARE quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • THYROCARE Financials
  • THYROCARE Shareholding Pattern
  • THYROCARE Earnings Documents
  • THYROCARE Announcements
  • THYROCARE Corporate Actions
  • THYROCARE Bulk, Block & Insider Deals
  • THYROCARE Delivery Data
  • THYROCARE Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Thyrocare Technologies Ltd (THYROCARE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Thyrocare Technologies Ltd reported sales of ₹271 Cr, operating profit of ₹89 Cr (OPM 33%) and net profit of ₹15 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

THYROCARE quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales166187193217196224240271
Expenses124130135145138149163182
Operating Profit4257587158757789
OPM25%30%30%33%30%34%32%33%
Other Income4553-155-41
Interest11110212
Depreciation1714111222141214
Profit before tax2847506335646834
Tax32%54%24%24%21%24%25%55%
Net Profit1922384828495115
EPS in Rs1.21.362.453.021.822.963.281
THYROCARE profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales589527572687829930
Expenses353403432498566631
Operating Profit236123140190263299
OPM40%23%24%28%32%32%
Other Income29991512-32
Interest356444
Depreciation343947555962
Profit before tax2288996145213202
Tax23%27%28%38%24%-
Net Profit176646991163143
EPS in Rs11.14.064.455.7610.249.06
Dividend Payout45%148%135%122%137%-
THYROCARE balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital535353159159
Reserves474494481426394
Borrowings4225255157
Other Liabilities75121121111115
Total Liabilities644693680747725
Fixed Assets306297301317289
CWIP314331
Investments162162146177168
Other Assets173220230250267
Total Assets644693680747725
THYROCARE cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity113129168191213
Cash from Investing Activity-24-39-91-53-23
Cash from Financing Activity-89-86-85-130-170
Net Cash Flow04-8821
Free Cash Flow9988107146198
CFO/OP72%128%141%123%104%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit72128141123104
THYROCARE ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days5859283933
Inventory Days53621048981
Days Payable365488146109
Cash Conversion Cycle756744-184
Working Capital Days413171319
ROCE42%17%18%25%35%
  • THYROCARE Shareholding Pattern
  • THYROCARE Earnings Concalls
  • THYROCARE Growth Catalysts
  • THYROCARE Corporate Actions
  • THYROCARE Announcements
  • THYROCARE Results & Documents
  • THYROCARE Bulk & Block Deals
  • THYROCARE Delivery Data